18.6% CAGR: Transcatheter Aortic Valve Replacement (TAVR) Market Hit Double Digit CAGR by 2023

The report is a comprehensive presentation of trends, forecast and dollar values of global transcatheter aortic valve replacement market. According to report the global transcatheter aortic valve replacement market is projected to grow at a CAGR of 18.6% over the forecast period of 2017-2023.

Logo

Pune, India -- (SBWire) -- 04/23/2019 --The Infinium Global Research analyzes the Transcatheter Aortic Valve Replacement (TAVR) Market over the period of 2017 to 2023. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size, and future trends in global transcatheter aortic valve replacement Market. It will help a lot of decision-makers to develop strategies and find new opportunities in the global markets of transcatheter aortic valve replacement.

Ask for Sample Copy of Research Report with Table of Content @ https://www.infiniumglobalresearch.com/reports/sample-request/306

The report covers market changing aspects including drivers, restraints, opportunities, and trends expected to encouragement the expansion of the transcatheter aortic valve replacement Market during the said period. The report also provides market attractiveness analysis, by geography, and market share analysis, by key players respectively. Some of the prominent participants in the global transcatheter aortic valve replacement Market are Edwards Lifesciences Corp., Boston Scientific Corp., Direct Flow Medical, Inc., Bracco SpA, JenaValve Technology, Inc., Medtronic plc, St. Jude Medical Inc., Meril Life Sciences Pvt. Ltd., and Transcatheter Technologies GmbH.

Transcatheter Aortic Valve Replacement Market: Industry Insight

Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure to replace the aortic valve in people suffering from aortic valve stenosis. Aortic valve stenosis or aortic stenosis is a narrowing of the aortic valve opening. This narrowing prevents the valve from opening to the fullest extent, which in turn obstructs blood flow from the heart into the aorta and further to the rest of the body. Symptoms of aortic stenosis include chest pain, fainting, fatigue, leg swelling and shortness of breath. Moreover, aortic stenosis can also lead to heart failure and sudden cardiac death. Transcatheter aortic valve replacement (TAVR) is a procedure which instead of removing the old, damaged valve, it wedges a replacement valve into the aortic valve's place and the tissue in the replacement valve carry out the job of regulating blood flow that has been obstructed.

Transcatheter Aortic Valve Replacement Market: Drivers and Restraints

An increasing number of patients across the world suffering from cardiovascular diseases such as heart failures, coronary artery diseases (CAD), and hypertension is one of the key factors augmenting the growth of transcatheter aortic valve replacement market. Cardiovascular diseases cause improper functioning of aortic valves, hereby stoking the demand for efficient valve replacement procedure. Moreover, along with technological advancements, increase in a number of clinical trials and patient awareness about the benefits of transcatheter aortic valve replacement procedure such as less traumatic surgical experience, reduced overall hospital stay, reduced healthcare expenditure in treating high-risk patients and faster recovery would meet the patients demand thus promoting market growth. However, stringent government regulations for approval of transcatheter aortic valve, the risk associated with the procedure hinder the growth of the market. Geographic expansions, increasing funding for research & development activities, new product launches, and favorable reimbursement policies are some of the key trends which are estimated to provide a better opportunity to the market during the forecast period.

Enquire here Get Customization & Check Discount for Report @ https://www.infiniumglobalresearch.com/reports/request-discount/306

Transcatheter Aortic Valve Replacement Market: Segmentation

Based on the type of treatment, the market is segregated into transfemoral implantation approach and transapical implantation approach. Transfemoral implantation holds the largest share in the market due to the advantage of minimally invasive procedure, less recovery time and hospitalization costs. Transapical implantation is estimated to be the growing segment during the forecast period owing to its ease of use and fewer complications than other surgical procedures. This procedure facilitates better passage for device entry with any diameter which provides better tissue longevity.

Transcatheter Aortic Valve Replacement Market: Regional Insight

Among the regions, Europe holds a largest regional share in the total TAVR market and maintain this trend due to the rise in presence of severe aortic stenosis cases along with the increase in a number of inoperable patients and high adoption rate of advanced transcatheter aortic valves. As per data published by Centers for Medicare and Medicaid Services (CMS), over 65 years of age the number of aortic stenosis patients is constantly increasing. Thus, in the U.S. rising incidence of aortic stenosis along with favorable reimbursement policies are expected to fillip the growth of the market over the forecast period. However, Asia Pacific is predicted to grow at a high CAGR (in terms of value and volume), mainly due to the presence of substantial growth opportunities in terms of unmet medical needs for the treatment of aortic stenosis and increase in awareness about TAVR procedures among physicians.

Transcatheter Aortic Valve Replacement Market: Competitive Analysis

Some of the major key players operating in global transcatheter aortic valve replacement (TAVR) Market are Edwards Lifesciences Corp, Boston Scientific Corp, Direct Flow Medical, Inc., Bracco Spa, Jenavalve Technology, Inc., Medtronic Plc, St. Jude Medical Inc., Meril Life Sciences Pvt. Ltd., and Transcatheter Technologies Gmbh among others

Browse Detailed TOC, Description, and Companies Mentioned in Report @
https://www.infiniumglobalresearch.com/healthcare-medical-devices/transcatheter-aortic-valve-replacement-tavr-market

Reasons to Buy this Report:

- Comprehensive analysis of global as well as regional markets of the Transcatheter Aortic Valve Replacement.

- Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2023.

- Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.

- Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Media Relations Contact

Shrikant Athavale
+919923950043
https://www.infiniumglobalresearch.com/

View this press release online at: http://rwire.com/1202041